Emyria |
Market Cap (5-Nov) $30,654,068 (923rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 0 |
Shortsold (29-Oct) 161,639 (0.02%) (557th) |
|
52w High $0.078 |
52w Low $0.036 |
P/E - |
EPS -0.01 |
Positive animal data for Emyrias ultra-pure CBD capsule
EMD released this announcement to the ASX on 15 December 2021, 9:50. The announcement is marked as price sensitive, and is 3 page(s) in length and 236.96kb in size.
You can view all announcements from EMD and see how they appear on a price chart on the announcements page.
At the date of this announcement, EMD was 0.086% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 557th as of the latest reported data (29 October 2026).
| Other Recent Announcements from EMD | |
|---|---|
| Trading Halt | 29 June 2023, 9:33 |
| Emyria Receives Ethics Approval for MDMA-assisted Therapy | 8 June 2023, 9:10 |
| Section 708A(5)(e) Notice | 10 May 2023, 18:37 |
| Positive animal data for Emyrias ultra-pure CBD capsule | 15 December 2021, 9:50 |
| Positive initial MDMA-analogue screening results | 8 December 2021, 9:44 |
| Change of Director's Interest Notice KS | 7 December 2021, 10:08 |
| Application for quotation of securities - EMD | 6 December 2021, 17:13 |
If you were already registered, log in here.